Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study

Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study

Abstract Background Self-administered subcutaneous immunoglobulin G (SCIg) reduces nursing time and eliminates the need for treatment at ambulatory care clinics, as compared with clinic-based intravenously administered IgG (IVIg), and are therapeutically equivalent. Estimating the economic impact of...

Full description

Bibliographic Details
Main Authors: Bruce Ritchie, Karen J. B. Martins, Dat T. Tran, Heather Blain, Lawrence Richer, Scott W. Klarenbach
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Immunoglobulin G
Subcutaneous
Intravenous
Home-based administration
Clinic-based administration
Administrative data
Online Access:https://doi.org/10.1186/s13223-022-00735-6

Internet

https://doi.org/10.1186/s13223-022-00735-6

Similar Items